Early detection of sporadic pancreatic cancer

Pancreatic cancer (PC) behaves very differently in comparison with other malignancies. Its prevalence continuously increases, mortality does not decrease, diagnosis is frequently late, radical surgery is limited to 15-20 % of patients, postoperative relapses are frequent, and chemotherapy has a palliative character. Preventive programs are the only possibility of improvement. In familial pancreatic cancer (FPC) the knowledge of the genetic mutation enables earlier entry of specialists into the surveillance program. The repeated use of high resolution imaging methods (including endoscopy and pancreatic cytology) may be followed by more frequent detection of the precursors and earlier stages of FPC. The identification of sporadic pancreatic cancer (SPC) depends fully on the construction of a multi-step and multi-disciplinary preventive program.

Medienart:

Artikel

Erscheinungsjahr:

2016

Erschienen:

2016

Enthalten in:

Zur Gesamtaufnahme - volume:155

Enthalten in:

Casopis lekaru ceskych - 155(2016), 1 vom: 22., Seite 44-7

Sprache:

Tschechisch

Weiterer Titel:

Časná detekce sporadického karcinomu pankreatu

Beteiligte Personen:

Frič, Přemysl [VerfasserIn]
Šedo, Aleksi [VerfasserIn]
Škrha, Jan [VerfasserIn]
Zima, Tomáš [VerfasserIn]
Bušek, Petr [VerfasserIn]
Škrha, Pavel [VerfasserIn]
Kmochová, Klára [VerfasserIn]
Laclav, Martin [VerfasserIn]
Bunganič, Bohuš [VerfasserIn]
Zavoral, Miroslav [VerfasserIn]

Themen:

Early detection
Early symptoms
Journal Article
Pancreatogenic diabetes
Review
Risk factors
Risk groups.
Sporadic pancreatic cancer

Anmerkungen:

Date Completed 29.06.2017

Date Revised 02.12.2018

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM25768705X